Pharming Group PHAR 深 沪
等待开盘 09-08 09:30:00 美东时间
11.23
-0.230
-2.01%
华盛通- 最 高11.54
- 今 开11.16
- 成交量 5544股
- 最 低 11.16
- 昨 收 11.46
- 总市值 7.95亿
- 52周最高 21.34
- 市盈率 静 293.21
- 换手率 0.01%
- 52周最低 9.62
- 委 比 98.65%
- 总股本 7077.81万
- 历史最高 21.99
- 量 比 0.42
- 振 幅 3.32%
- 历史最低 6.10
- 每 手 1
- 风险率 2.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Pharming Group shares are trading higher after the company announced the commercial launch of Joenja in Japan for adult and pediatric patients with activated PI3K delta syndrome aged 4 years and older.
Pharming Group shares are trading higher after the company announced the commercial launch of Joenja in Japan for adult and pediatric patients with activated PI3K delta syndrome aged 4 years and older.
08-14 03:06
Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older
Pharming Group has launched Joenja® (leniolisib) in Japan for adults and children aged 4 and older with Activated PI3K delta Syndrome (APDS). Japan is the first market where Joenja is commercially available for children aged 4-11. OrphanPacific, Inc. serves as the Marketing Authorization Holder and is responsible for supply and distribution in Japan. Joenja, an oral PI3Kδ inhibitor, was approved by Japan's Ministry of Health, Labour and Welfare i...
08-13 05:00
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Canaccord Genuity Maintains Buy on Pharming, Raises Price Target to $38
Canaccord Genuity analyst Whitney Ijem maintains Pharming (NASDAQ:PHAR) with a Buy and raises the price target from $37 to $38.
08-04 05:28
Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday. Shares of Meta Platforms Inc (NASDAQ:META) fell sharply in pre-market trading after the company posted mixed financial results for the second quarter. Meta reported second-quarter revenue of $60.80 bil...
07-30 20:03
Pharming Lowers FY2026 Sales Guidance from $405.000M-$425.000M to $375.000M-$395.000M vs $419.100M Est
Pharming (NASDAQ:PHAR) lowers FY2026 sales outlook from $405.000 million-$425.000 million to $375.000 million-$395.000 million vs $419.100 million estimate.
07-30 15:49
Pharming Q2 EPS $0.02, Inline, Sales $90.200M Miss $100.625M Estimate
Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 66.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $90.200 million which missed the analyst consensus...
07-30 13:07
Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30
Pharming Group N.V. will report its preliminary financial results for the second quarter and first half of 2026, along with a business update, on July 30, 2026. A conference call and webcast for analysts and investors will be held at 13:30 CEST/07:30 am EDT on the same day. Registration links for the conference call and webcast are provided, and participants will receive dial-in information and a unique PIN upon registration. The webcast will als...
07-16 06:00
Pharming Says FDA Accepts Joenja Application for Younger Children
Pharming Group ((Euronext: PHARM, NASDAQ:PHAR) today announced that the U.S. Food and Drug Administration (FDA) has accepted its resubmitted supplemental New Drug Application (sNDA) seeking approval for Joenja®
06-04 16:21
Pharming Group announces results of 2026 Annual General Meeting of Shareholders
Pharming Group shareholders approved all proposals at the 2026 Annual General Meeting, including appointing KPMG as the external auditor for 2026-2028, amending the Board's remuneration policy, and renewing share issuance and repurchase authorizations. Meeting materials are available on the company's website.
05-28 14:40
